Skip to main content

Table 1 Patients’ characteristics

From: Lack of impact of iodinated contrast media on kidney cell-cycle arrest biomarkers in critically ill patients

 

n = 77

Age (years)

64 [53; 70]

Female gender

19 (25%)

Comorbidities

 Chronic kidney disease

5 (7%)

 Hypertension

26 (34%)

 Diabetes

14 (18%)

 Cancer

26 (34%)

 Cirrhosis

3 (4%)

 Congestive heart failure

4 (5%)

 Chronic obstructive pulmonary disease

1 (1%)

Main ICU admission diagnosis

 Acute respiratory failure

26 (34%)

 Coma

19 (25%)

 Sepsis or septic shock

12 (16%)

 Other shock

8 (10%)

 Exacerbation of chronic respiratory failure

3 (4%)

 Cardiac arrest

2 (3%)

 Multiple organ failure

2 (3%)

 Other

5 (6%)

SAPSa II at admission

46 [35; 56]

Serum creatinine concentration at inclusion (μmol/L)

69 [48; 109]

Computed tomography explored areab

 Brain

29 (38%)

 Thorax

40 (52%)

 Abdomen

29 (38%)

 Pelvis

26 (34%)

 Soft tissue/limbs

1 (1%)

 Spine

1 (1%)

Iodinated contrast medium infused

 Iohexol 300 mg/mL iodine

3 (4%)

 Iohexol 350 mg/mL iodine

26 (34%)

 Iobitridol 350 mg/mL iodine

26 (34%)

 Iopromide 370 mg/mL iodine

17 (22%)

 Iomeprol 350 mg/mL iodine

1 (1%)

 Iomeprol 400 mg/mL iodine

4 (5%)

Volume of iodinated contrast medium infused (mL)

96 [60; 120]

  1. Qualitative variables are reported as count (percentage) and quantitative variables as median [first; third quartiles]
  2. asimplified acute physiology score
  3. bpercentages add up to more than 100% because a given patient may have had several anatomic regions explored within one imaging procedure